Almaden Genomics Introduces g.nome® 2.0, a Platform Enhancement to Empower Data Analysis and Interpretation

Audio By Carbonatix

DALLAS--(BUSINESS WIRE)--Jan 13, 2025--

Almaden Genomics has announced g.nome ® 2.0, a significant upgrade to its flagship platform to empower researchers and biologists with enhanced data analysis capabilities and streamlined workflows. These enhancements further the company’s mission to make bioinformatics tools more accessible, efficient, and powerful for the life sciences industry.

Key among the new features is the introduction of g.nome Analytics, which connects bioinformatics workflows directly to biologist-friendly analysis tools. This feature enables users to explore data deeper through do-it-yourself tertiary analysis and advanced visualizations. With this enhancement, researchers can gain critical insights from their data faster and more intuitively.

“The launch of g.nome Analytics underscores our dedication to empowering researchers with tools that make complex statistical and AI/ML models more approachable,” said David Gascoigne, CEO of Almaden Genomics. “By enabling seamless integration from raw data to exploratory analysis, we’re ensuring that scientists can access meaningful insights with greater ease, transforming how they approach their work.”

Additionally, g.nome now allows users to leverage Nextflow-built bioinformatics workflows. By adopting this industry-leading standard into g.nome, researchers can utilize complex pipelines through a user-friendly, guided interface. This breakthrough feature ensures biologists can independently run sophisticated analyses without requiring deep bioinformatics knowledge.

The platform has also undergone a comprehensive user interface upgrade. With improved tools for tracking, building, and running workflows, as well as enhanced project organization features, g.nome makes managing large-scale bioinformatics projects more seamless than ever.

“We are removing barriers between biologists and the data insights they need,” said Kit Fuhrman, VP of Product at Almaden Genomics, “Whether it's the new g.nome Analytics for deeper exploration or the ability to simplify bioinformatics workflows, these tools are designed to empower researchers to focus on discovery, not complexity.”

Almaden Genomics’ bioinformatics services complement the g.nome platform, offering bespoke solutions for data analysis and management. From designing data workflows to implementing advanced analytics, the company supports researchers in achieving groundbreaking results.

About Almaden Genomics

Almaden Genomics is a leader in bioinformatics and data management, providing cutting-edge computational solutions for the life sciences industry. With expertise in AI-driven research and cloud-based data handling, Almaden Genomics supports innovation in drug discovery, diagnostics, and biotech research. Almaden Genomics is a Catalyze Partners portfolio company. For more information, visit almaden.io.

View source version on businesswire.com:https://www.businesswire.com/news/home/20250113178618/en/

CONTACT: Media Contact:

Meleena Loseke

[email protected]

469-480-3865

KEYWORD: CALIFORNIA PENNSYLVANIA TEXAS UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: BIOMETRICS OTHER HEALTH OTHER SCIENCE PHARMACEUTICAL RESEARCH SOFTWARE ARTIFICIAL INTELLIGENCE GENETICS DATA MANAGEMENT PROFESSIONAL SERVICES STEM CELLS SCIENCE TECHNOLOGY GENERAL HEALTH DATA ANALYTICS BIOTECHNOLOGY HEALTH HEALTH TECHNOLOGY

SOURCE: Almaden Genomics

Copyright Business Wire 2025.

PUB: 01/13/2025 12:00 PM/DISC: 01/13/2025 11:57 AM

http://www.businesswire.com/news/home/20250113178618/en